Bath & Body Works logged a 0.3% change during today's morning session, and is now trading at a price of $43.7 per share.
Bath & Body Works returned losses of -6.8% last year, with its stock price reaching a high of $49.55 and a low of $27.3. Over the same period, the stock underperformed the S&P 500 index by -30.4%. As of April 2023, the company's 50-day average price was $34.81. Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. Based in Columbus, OH, the mid-cap Consumer Cyclical company has 8,800 full time employees. Bath & Body Works has offered a 1.8% dividend yield over the last 12 months.
The Company's Revenues Are Declining:
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue (MM) | $12,632 | $13,237 | $5,405 | $6,434 | $7,882 | $7,560 |
| Revenue Growth | n/a | 4.79% | -59.17% | 19.04% | 22.51% | -4.09% |
| Operating Margins | 14% | 9% | 19% | 25% | 25% | 18% |
| Net Margins | 8% | 5% | -7% | 13% | 17% | 11% |
| Net Income (MM) | $983 | $644 | -$366 | $844 | $1,333 | $794 |
| Net Interest Expense (MM) | $406 | $385 | $370 | $432 | $388 | -$348 |
| Diluted Shares (MM) | 275 | 276 | 283 | 267 | 229 | 229 |
| Free Cash Flow (MM) | $699 | $748 | $778 | $1,811 | $1,222 | $816 |
| Capital Expenditures (MM) | $707 | $629 | $458 | $228 | $270 | $328 |
| Current Ratio | 1.37 | 1.15 | 1.48 | 2.08 | 1.34 | 1.56 |
| Total Debt (MM) | $5,763 | $5,814 | $6,375 | $4,852 | $4,860 | $4,668 |
Bath & Body Works Is Reasonably Priced:
Bath & Body Works has a trailing twelve month P/E ratio of 11.1, compared to an average of 22.96 for the Consumer Cyclical sector. Based on its EPS guidance of $3.3, the company has a forward P/E ratio of 10.5.
Bath & Body Works Has an Average Rating of Buy:
The 18 analysts following Bath & Body Works have set target prices ranging from $30.0 to $60.0 per share, for an average of $40.89 with a buy rating. As of April 2023, the company is trading -14.9% away from its average target price, indicating that there is an analyst consensus of little upside potential.
Bath & Body Works has an average amount of shares sold short because 5.1% of the company's shares are sold short. Institutions own 98.4% of the company's shares, and the insider ownership rate stands at 0.43%, suggesting a small amount of insider investors. The largest shareholder is Vanguard Group Inc, whose 11% stake in the company is worth $1,122,633,048.
